<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: <z:hpo ids='HP_0000855'>Insulin resistance</z:hpo> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> have been associated with ectopic <z:mpath ids='MPATH_42'>lipid deposition</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>This study investigates the derangements in postprandial <z:chebi fb="23" ids="18059">lipid</z:chebi> handling in liver and skeletal muscle tissue at different stages during the pathogenesis of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in a rat model </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Four groups (n = 6) of male <z:chebi fb="3" ids="16646">Zucker</z:chebi> diabetic fatty rats were used for this study: <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetic</z:e> fa/fa rats and healthy fa/+ littermates at the age of 6 weeks, and diabetic fa/fa rats and healthy fa/+ littermates at the age of 12 weeks </plain></SENT>
<SENT sid="3" pm="."><plain>In vivo (1)H-[(13)C] magnetic resonance spectroscopy measurements were performed in liver and tibialis anterior muscle at baseline and 4, 24 and 48 h after oral administration of 1.5 g [U-(13)C]algal <z:chebi fb="23" ids="18059">lipid</z:chebi> mixture per kilogram body weight </plain></SENT>
<SENT sid="4" pm="."><plain>Total and (13)C-labelled intracellular <z:chebi fb="23" ids="18059">lipid</z:chebi> contents were determined from the magnetic resonance spectra </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: In both <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetic</z:e> and diabetic rats, total <z:chebi fb="23" ids="18059">lipid</z:chebi> contents in muscle and liver were substantially higher than in healthy controls and this was accompanied by a 2.3-fold greater postprandial <z:chebi fb="23" ids="18059">lipid</z:chebi> uptake in the liver (p &lt; 0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>Interestingly, in <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetic</z:e> rats, skeletal muscle appeared to be protected from excess <z:chebi fb="23" ids="18059">lipid</z:chebi> uptake whereas after developing overt <z:mp ids='MP_0002055'>diabetes</z:mp> muscle <z:chebi fb="23" ids="18059">lipid</z:chebi> uptake was 3.4-fold higher than in controls (p &lt; 0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>Muscle <z:chebi fb="23" ids="18059">lipid</z:chebi> use was significantly lower in <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetic</z:e> and diabetic muscle, indicative of impairments in <z:chebi fb="23" ids="18059">lipid</z:chebi> oxidation </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS/INTERPRETATION: In vivo postprandial <z:chebi fb="23" ids="18059">lipid</z:chebi> handling is disturbed in both liver and skeletal muscle tissue in <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetic</z:e> and diabetic rats, but the uptake of dietary <z:chebi fb="23" ids="18059">lipids</z:chebi> in muscle is only increased after the development of overt <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>